secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-07-21T20:15:45+00:00
Accession:  0001477932-26-004421
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx reduces authorized common shares from 325M to 150M after stockholder vote
--------------------------------------------------------------------------------

- Authorized common shares cut from 325M to 150M via Certificate of Fourth Amendment filed July 17, 2026.
- Stockholders approved the amendment with 4,011,189 votes for, 218,947 against at 2026 annual meeting.
- All seven director nominees elected; Sadler, Gibb ratified as auditor for FY2026.
- 2026 Stock Incentive Plan approved by stockholders (2,078,833 for, 182,048 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226004421/0001477932-26-004421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226004421/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-004421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer